A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies
Clinical trial NCT04850755 · COMPLETED
Trial details
- NCT number
- NCT04850755
- Sponsor
- National University Hospital, Singapore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2025-03-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.